ASH issues guidance for preventing, treating VTE in cancer

FDA-approved antidiarrhea drug can reverse resistance to chemotherapy in a mouse model of leukemia
1 March 2021
Potential target for treating many cancers found within GLI1 gene
1 March 2021

ASH issues guidance for preventing, treating VTE in cancer

(HealthDay)—In a clinical guideline from the American Society of Hematology, published online Feb. 11 in Blood Advances, recommendations are presented for the prevention and treatment of venous thromboembolism (VTE) in patients with cancer.

Comments are closed.